This suggests that the enhancement of NPs through neprilysin inhibition is an effective approach to improve the BP-lowering effect associated with RAS inhibition in patients with a low-or less-responsive RAS (e.g. salt-sensitive or elderly patients with hypertension) [38]. The gene discussed is MME; the disease is hypertensive disorder.